| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/09/1995 | US5414009 Azabicyclo substituted oxa- or thia-diazole compounds |
| 05/09/1995 | US5414004 Neurotransmitter releasers useful for cognition enhancement |
| 05/09/1995 | US5414002 5- or 6-substituted β-carboline-3-carboxylic acid esters |
| 05/09/1995 | CA1335502C Psychotropic bicyclic imides |
| 05/04/1995 | WO1995011903A1 Tricyclic compounds having affinity for the 5-ht1a receptor |
| 05/04/1995 | WO1995011901A1 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
| 05/04/1995 | WO1995011894A1 Histamine h3-receptor antagonists and therapeutic uses thereof |
| 05/04/1995 | WO1995011891A1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes |
| 05/04/1995 | WO1995011887A1 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers |
| 05/04/1995 | WO1995011885A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 05/04/1995 | WO1995011702A1 Prokaryotic expression of mhc proteins |
| 05/04/1995 | WO1995011680A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 05/04/1995 | WO1995011679A1 Use of lobeline for the treatment of nicotine withdrawal |
| 05/04/1995 | WO1995011678A1 Use of nicotine substitutes for the treatment of nicotine withdrawal |
| 05/04/1995 | WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/04/1995 | WO1994028132A3 Opioid receptors: compositions and methods |
| 05/04/1995 | CA2175089A1 Prokaryotic expression of mhc proteins |
| 05/04/1995 | CA2174850A1 Tricyclic compounds having affinity for the 5-ht1a receptor |
| 05/04/1995 | CA2174747A1 Use of lobeline for the treatment of nicotine withdrawal |
| 05/03/1995 | EP0650966A1 Process for the preparation of a benzo(a)quinolizinone derivative |
| 05/03/1995 | EP0650964A1 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives |
| 05/03/1995 | EP0650486A1 New analgesic and nootropic drugs |
| 05/03/1995 | EP0650483A1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS |
| 05/03/1995 | EP0650475A1 4-amino-n --(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 05/03/1995 | EP0650355A1 Medicaments for the treatment of visceral pain and migraine |
| 05/03/1995 | EP0644937A4 Therapeutic and diagnostic methods based on neurotrophin-4 expression. |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/03/1995 | CA2134630A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives |
| 05/02/1995 | US5411976 New thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same |
| 05/02/1995 | US5411955 Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals |
| 05/02/1995 | US5411740 Transdermal administration of oxybutynin |
| 05/02/1995 | US5411739 Transdermal delivery of nicotine |
| 04/27/1995 | WO1995011253A1 A method for enhancing neurone survival and agents useful for same |
| 04/27/1995 | WO1995011244A1 Pyridazino quinoline compounds |
| 04/27/1995 | WO1995011243A1 Benzanilide derivatives as 5ht-1d receptor antagonists |
| 04/27/1995 | WO1995011240A1 Amine derivatives as calcium channel antagonists |
| 04/27/1995 | WO1995011239A1 Novel phenoxyalkylpiperazine derivative |
| 04/27/1995 | WO1995011238A1 Heterocyclic amines for treating ischaemic strokes |
| 04/27/1995 | WO1995011031A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/27/1995 | WO1995011027A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
| 04/27/1995 | WO1995011021A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents |
| 04/27/1995 | WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 04/27/1995 | WO1995002409A3 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 04/27/1995 | CA2174425A1 A method for enhancing neurone survival and agents useful for same |
| 04/27/1995 | CA2174240A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
| 04/27/1995 | CA2171332A1 Pyridazino quinoline compounds |
| 04/27/1995 | CA2152357A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/26/1995 | EP0649846A1 Galanthamine derivates, a process for their preparation and their use as medicaments |
| 04/26/1995 | EP0649657A1 Pharmaceutical combinations containing a NSAID and an opioid analgesic |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649419A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 04/26/1995 | EP0649418A1 7-(2-aminoethyl)-benzothiazolones |
| 04/26/1995 | EP0649414A1 Opioid diarylmethylpiperazines and piperidines |
| 04/26/1995 | EP0649407A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 04/26/1995 | EP0524180B1 Taste masking of ibuprofen by fluid bed coating |
| 04/26/1995 | EP0521070B1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 04/26/1995 | CN1102040A Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/25/1995 | US5410057 1-heteroarylazetidines and -pyrrolidines |
| 04/25/1995 | US5410049 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 04/25/1995 | US5409948 Method for treating cognitive disorders with phenserine |
| 04/25/1995 | US5409946 Antiepileptic agent |
| 04/25/1995 | US5409940 3,4-dehydropiperidine derivatives |
| 04/25/1995 | US5409935 Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas |
| 04/25/1995 | US5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 04/25/1995 | US5409929 Hydroisoindolines and hydroisoquinolines as psychotropic drugs |
| 04/25/1995 | CA1335379C Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335378C Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335346C Method of treating erectile dysfunction |
| 04/23/1995 | CA2132883A1 1-amino-ethylindole-derivatives |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010611A1 Method of inducing and maintaining neuronal cells |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010521A1 Therapeutic agents |
| 04/20/1995 | WO1995010517A1 Indole derivatives as nmda antagonists |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | WO1995010286A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/20/1995 | WO1995010277A1 Analgesic agent and its use |
| 04/20/1995 | WO1995010276A1 Levobupivacaine useful for managing chronic pain |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | CA2614621A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2173857A1 Therapeutic agents |
| 04/20/1995 | CA2173456A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2171449A1 Indole derivatives as nmda antagonists |
| 04/19/1995 | EP0648771A1 Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 04/19/1995 | EP0648769A1 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof |
| 04/19/1995 | EP0648767A1 Piperdine and piperazine derivatives which affect the C.N.S. |
| 04/19/1995 | EP0648766A1 Agent acting on the central nervous system, method for its preparation and pharmaceutical compositions containing such agent |
| 04/19/1995 | EP0648762A2 Bicyclic compounds as excitatory amino acid receptor antagonists |
| 04/19/1995 | EP0648758A1 4-Arylamino-benzopyran and related compounds |
| 04/19/1995 | EP0648745A1 Arylalkylamine having anticonvulsant and neuroprotective properties |
| 04/19/1995 | EP0648744A1 Phenylalkanolamine derivatives as antagonists of the NMDA receptor |
| 04/19/1995 | EP0648489A1 Arylalkylamides having neuroprotective properties |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648227A1 Improvements in or relating to neuroregeneration |
| 04/19/1995 | EP0648213A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/19/1995 | EP0648117A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances. |